FI934461A0 - Antitumoer- och antipsoriasismedel - Google Patents

Antitumoer- och antipsoriasismedel

Info

Publication number
FI934461A0
FI934461A0 FI934461A FI934461A FI934461A0 FI 934461 A0 FI934461 A0 FI 934461A0 FI 934461 A FI934461 A FI 934461A FI 934461 A FI934461 A FI 934461A FI 934461 A0 FI934461 A0 FI 934461A0
Authority
FI
Finland
Prior art keywords
antitumoer
antipsoriisisededel
och
och antipsoriisisededel
Prior art date
Application number
FI934461A
Other languages
English (en)
Finnish (fi)
Other versions
FI934461A7 (fi
FI934461L (fi
Inventor
Stuart W Mccombie
Bandarpalle B Shankar
Michael P Kirkup
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI934461A7 publication Critical patent/FI934461A7/fi
Publication of FI934461L publication Critical patent/FI934461L/fi
Publication of FI934461A0 publication Critical patent/FI934461A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI934461A 1991-04-11 1992-04-09 Antitumoer- och antipsoriasismedel FI934461A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68377091A 1991-04-11 1991-04-11
PCT/US1992/002661 WO1992018507A1 (en) 1991-04-11 1992-04-09 Anti-tumor and anti-psoriatic agents

Publications (3)

Publication Number Publication Date
FI934461A7 FI934461A7 (fi) 1993-10-11
FI934461L FI934461L (fi) 1993-10-11
FI934461A0 true FI934461A0 (fi) 1993-10-11

Family

ID=24745378

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934461A FI934461A0 (fi) 1991-04-11 1992-04-09 Antitumoer- och antipsoriasismedel

Country Status (14)

Country Link
EP (2) EP0508792A1 (OSRAM)
JP (1) JPH06503837A (OSRAM)
CA (1) CA2108146A1 (OSRAM)
CZ (1) CZ213693A3 (OSRAM)
FI (1) FI934461A0 (OSRAM)
HU (1) HUT70187A (OSRAM)
IE (1) IE921148A1 (OSRAM)
IL (1) IL101554A0 (OSRAM)
MX (1) MX9201643A (OSRAM)
NO (1) NO933611L (OSRAM)
NZ (1) NZ242294A (OSRAM)
SK (1) SK108293A3 (OSRAM)
TW (1) TW214553B (OSRAM)
WO (1) WO1992018507A1 (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ245203A (en) * 1991-11-29 1997-07-27 Banyu Pharma Co Ltd 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
ES2136103T3 (es) * 1992-06-22 1999-11-16 Kyowa Hakko Kogyo Kk Procedimiento para la preparacion de derivados de estaurosporina.
AU5100393A (en) * 1992-09-25 1994-04-26 Schering Corporation Diindolo compounds and pharmaceutical compositions containing them
PL182124B1 (pl) * 1993-12-07 2001-11-30 Lilly Co Eli Nowe zwiazki oraz srodek farmaceutyczny przeznaczony do leczenia powiklan cukrzycowych lub do leczenia nowotworów PL PL PL PL PL PL PL PL
US5843935A (en) * 1993-12-07 1998-12-01 Eli Lilly And Company Protein kinase C inhibitors
US5723456A (en) * 1993-12-07 1998-03-03 Eli Lilly & Company Therapeutic treatment for cardiovascular diseases
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
AU1911095A (en) * 1994-02-18 1995-09-04 Cephalon, Inc. Aqueous indolocarbazole solutions
WO1997005140A1 (en) * 1995-07-31 1997-02-13 Novartis Ag Trindene compounds
US20040037828A1 (en) * 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
FR2826653B1 (fr) * 2001-06-29 2005-10-14 Servier Lab Nouveaux derives de pyrido-pyrido-pyrrolo[3,2-g]pyrrolo [3,4-e]-indole et pyrido-pyrrolo[2,3-a]pyrrolo[3,4-c] carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
TWI335221B (en) 2001-09-27 2011-01-01 Alcon Inc Inhibtors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
CA2535029C (en) 2003-08-07 2013-07-16 Healor Ltd. Pharmaceutical compositions and methods for accelerating wound healing
AU2006286152B2 (en) 2005-08-29 2012-05-31 Healor Ltd. Methods and compositions for prevention and treatment of diabetic and aged skin
EP2181999A1 (en) 2008-11-03 2010-05-05 Zentiva, A.S. Method of manufacturing ruboxistarin
RU2012133148A (ru) 2010-01-11 2014-02-20 Хилор Лтд. Способ лечения воспалительного заболевания и расстройства
US20170209488A1 (en) 2014-07-17 2017-07-27 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods for treating neuromuscular junction-related diseases
WO2016207366A1 (en) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of viral infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0303697B1 (en) * 1987-03-09 1997-10-01 Kyowa Hakko Kogyo Co., Ltd. Derivatives of physiologically active substance k-252
DE3924538A1 (de) * 1989-07-25 1991-01-31 Goedecke Ag Indolocarbazol und dessen verwendung

Also Published As

Publication number Publication date
FI934461A7 (fi) 1993-10-11
IE921148A1 (en) 1992-10-21
IL101554A0 (en) 1992-12-30
FI934461L (fi) 1993-10-11
WO1992018507A1 (en) 1992-10-29
SK108293A3 (en) 1994-09-07
HU9302869D0 (en) 1993-12-28
NO933611D0 (no) 1993-10-08
TW214553B (OSRAM) 1993-10-11
AU1798292A (en) 1992-11-17
EP0508792A1 (en) 1992-10-14
HUT70187A (en) 1995-09-28
NO933611L (no) 1993-10-08
JPH06503837A (ja) 1994-04-28
CZ213693A3 (en) 1994-05-18
AU646163B2 (en) 1994-02-10
NZ242294A (en) 1993-07-27
EP0580812A1 (en) 1994-02-02
MX9201643A (es) 1992-10-01
CA2108146A1 (en) 1992-10-12

Similar Documents

Publication Publication Date Title
DE69212332D1 (de) Farbball
DE59206583D1 (de) Windsichter
DE69219551D1 (de) Überrahmen
ATE137279T1 (de) Stoffauflauf
FI934095L (fi) Biodegraderande kompositioner innehaollande staerkelse
DE59209976D1 (de) Flaschendispenser
DE69219252D1 (de) Ölbehälter
FI924280A7 (fi) Differentialfoerstaerkarkoppling
FI934461A0 (fi) Antitumoer- och antipsoriasismedel
BR9204511A (pt) Recolhedor-enrolador
DE59208716D1 (de) Lymphoides cd30-antigen
DE69126968D1 (de) Tamburin
DE69230668D1 (de) Imaginograph
NO922609D0 (no) Kjoelesystem
DE69232673D1 (de) Tiefsttemperaturmessausrüstung
ATE163916T1 (de) Ethyl-6-formyloxy-4-hexenoat
DE69220547D1 (de) 5-substituierte-2-Oxazolidinone
FI934287L (fi) Foerbaettrad ploejningsanordning
ATA9892A (de) Formstein
BR9201945A (pt) Filatorio
DE69224122D1 (de) Kephalostat
CA68725S (fr) Mobilier-jeu
BR7102405U (pt) Chutegol
BR9100265A (pt) Assadeira multiutilitaria
BR9100789A (pt) Troca-roda

Legal Events

Date Code Title Description
FD Application lapsed